Xiong D T, Cheng F, Xu J Z, Wang J H, Zhang Y F, Cai Y Y, Gan W J, Li X Q, Wang Z M, Yu F
Department of Pathology, the Fourth Affiliated Hospital of Soochow University, Suzhou 215000, China Department of Pathology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Department of Pathology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Zhonghua Xue Ye Xue Za Zhi. 2025 Jul 14;46(7):642-646. doi: 10.3760/cma.j.cn121090-20241120-00459.
This study sought to examine the clinicopathological features of monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) and to discuss its differential diagnosis. A total of 36 MEITL cases, collected between June 2015 and January 2024 from the Fourth Affiliated Hospital of Soochow University and the First Affiliated Hospital, College of Medicine, Zhejiang University, were analyzed. Patients underwent immunohistochemistry, in situ hybridization for Epstein-Barr virus-encoded small RNA (EBER), and T-cell receptor (TCR) gene rearrangement testing. Clinical data, laboratory results, and follow-up information were collected for correlation analysis. The cohort included 36 patients (20 males and 16 females) aged 17-76 years (median: 57 years). Tumors outside the intestine were observed in 22 cases (61%). A total of 32 patients (89%) underwent surgical intervention and/or chemotherapy, and one patient received auto-HSCT. The median follow-up duration was 11.5 months (range: 8-73 months), with a median overall survival of 6 months (range: 1-67 months) ; 34 patients died during the follow-up period. Morphologically, nine cases (25%) exhibited significant pleomorphism. Immunohistochemical analysis revealed that high expression levels of both P53 and c-Myc were correlated with atypical morphology (=0.003 and =0.016, respectively). Notably, patients with high P53 expression had significantly shorter survival times than those with low P53 expression ((2)=4.922, =0.027), whereas survival did not differ significantly based on c-Myc expression levels ((2)=0.034, =0.854). Furthermore, a PD-L1 CPS score ≥10 was observed in 22 cases (68.8%). Scattered EBER positivity in background cells was identified in four cases. All tested cases (17/17, 100.0%) showed clonal TCR gene rearrangements. MEITL is a rare but highly aggressive lymphoma with distinct clinical and pathological features. A subset of cases may exhibit atypical morphological patterns, complicating the diagnostic process. Improving awareness of this neoplasm is helpful for early and precise diagnosis as well as the estabolishment of novel therapy regimen.
本研究旨在探讨单形性上皮样肠道T细胞淋巴瘤(MEITL)的临床病理特征并讨论其鉴别诊断。分析了2015年6月至2024年1月期间从苏州大学附属第四医院和浙江大学医学院附属第一医院收集的36例MEITL病例。患者接受了免疫组织化学、爱泼斯坦-巴尔病毒编码小RNA(EBER)原位杂交以及T细胞受体(TCR)基因重排检测。收集临床数据、实验室结果和随访信息进行相关性分析。该队列包括36例患者(20例男性和16例女性),年龄在17至76岁之间(中位数:57岁)。22例(61%)观察到肠道外肿瘤。共有32例患者(89%)接受了手术干预和/或化疗,1例患者接受了自体造血干细胞移植。中位随访时间为11.5个月(范围:8至73个月),中位总生存期为6个月(范围:1至67个月);34例患者在随访期间死亡。形态学上,9例(25%)表现出明显的多形性。免疫组织化学分析显示,P53和c-Myc的高表达水平均与非典型形态相关(分别为=0.003和=0.016)。值得注意的是,P53高表达患者的生存时间明显短于P53低表达患者((2)=4.922,=0.027),而基于c-Myc表达水平的生存情况无显著差异((2)=0.034,=0.854)。此外,22例(68.8%)观察到PD-L1 CPS评分≥10。4例在背景细胞中发现散在的EBER阳性。所有检测病例(17/17,100.0%)均显示克隆性TCR基因重排。MEITL是一种罕见但侵袭性很强的淋巴瘤,具有独特的临床和病理特征。一部分病例可能表现出非典型形态模式,使诊断过程复杂化。提高对这种肿瘤的认识有助于早期精确诊断以及建立新的治疗方案。